The market for oxygen therapy is expected to grow as a consequence of a number of factors, including the escalating incidence of respiratory disorders, the swiftly aging population, the high prevalence of tobacco use, the need for at-home oxygen therapy, and technological advancements.
The availability of low-cost alternatives produced locally, stringent regulatory procedures that delay product approvals, and Medicare payment rate decreases for home oxygen therapy in the United States are all expected to somewhat restrain market development.
The market's major players have lately launched revolutionary goods, and they have plans to continue doing so in the future as well as expand geographically and launch new products.
The COVID-19 pandemic had a significant impact on the medical equipment industry because of lockdown laws and problems with supply chain management. However, oxygen therapy equipment remained in great demand throughout the crisis since it was the primary line of treatment for severely ill patients with coronavirus infections. Due to a serious global ventilator shortage, demand for oxygen concentrators increased. In order to get around this shortage, biomedical engineers and scientists have developed interim systems that replicate the key components of ventilators using already-existing equipment including oxygen concentrators, PAP machines, anaesthetic machines, and manual resuscitators.
The Global Oxygen Therapy Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Allied Healthcare Products, Inc., Andreas Fahl Medizintechnik-Vertriebs GmbH, Becton, Dickinson and Company, CAIRE, Chart Industries, Inc., DeVilbiss Healthcare Drägerwerk AG & Co. KGaA, Essex Industries, Inc., Fisher & Paykel Healthcare Corporation Limited, GCE Holding AB, GE Healthcare, Heinen + Löwenstein GmbH & Co. KG, HERSILL S.L., HUM - Gesellschaft für Homecare und Medizintechnik mbH, Inogen, Inc., Invacare Corporation, IUC Medical, Linde Healthcare, Medicap homecare GmbH, Medicop D.O.O., Messer Medical Austria GmbH, Philips Healthcare, Philips Respironics, Inc., ResMedDrägerwerk AG & Co. KGaALinde, Respan Products Inc., Smiths Medical, Taiyo Nippon Sanso Corporation, Tecno-Gaz IndustriesTeleflex Incorporated, Weinmann Emergency Medical Technology GmbH + Co. KG.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for product type segment – By Product [Oxygen Source Equipment (Oxygen Concentrators, Liquid Oxygen Devices, Oxygen Cylinders, PAP Devices), Oxygen Delivery Devices (Oxygen Masks, Nasal Cannulas, Venturi Masks, Non-rebreather Masks, Bag-valve Masks, CPAP Masks), Other Oxygen Delivery Devices], By Portability (Stationary Devices and Portable Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Respiratory Distress Syndrome, Pneumonia, Other Diseases), By End Use (Home Healthcare, Non-Home Healthcare, Ambulatory Surgical Centers & Physician Offices).
This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.